Compare Hewlett Packard Enterprise Co (HPE) vs Humana Inc (HUM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hewlett Packard Enterprise Co vs Humana Inc — how do they compare? Hewlett Packard Enterprise Co trades at $48.33 (market cap $59.01B), while Humana Inc trades at $402.89 (market cap $47.81B). The key difference: Hewlett Packard Enterprise Co is the larger of the two by market cap, and Hewlett Packard Enterprise Co pays the higher dividend (1.28%). Which is the better fit depends on your goals.
| HPE | HUM | |
|---|---|---|
Market Cap | $59.01B | $47.81B |
Sector | Technology | Health |
52-Week High | $56.14 | $409.42 |
52-Week Low | $19.81 | $163.67 |
Enterprise Value | $74.96B | $56.85B |
Dividend Yield | 1.28% | 0.89% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HPE trades at $46.73, up 1.99% today, with a bullish technical signal and strong recent earnings beats. The stock is supported by a $6.3 billion AI backlog and a strategic shift toward high-margin networking, which now drives 44% of segment profit. Revenue grew to $34.3 billion in 2025, though net income fell sharply to $57 million due to heavy investment. Analysts maintain a consensus price target of $69.69, implying significant upside.
Outlook is positive given AI infrastructure demand and networking momentum, but risks include execution on large investments, competitive pressures, and volatile cash flows. The stock offers growth potential if margin expansion continues, yet investors must monitor debt levels and earnings consistency amid macroeconomic uncertainty.
Humana (HUM) trades at $404.80, up 1.2% on the day, with a bullish technical signal and recent earnings beats. Revenue has grown steadily to $129.66 billion in 2025, though net income margin has compressed to 0.82%. The company is focused on margin recovery in its Medicare Advantage business and expanding its CenterWell healthcare services segment.
The stock faces headwinds from declining profitability and regulatory scrutiny, but analyst consensus leans Hold with a $354.33 price target below the current price. Upside depends on successful execution of its 2028 margin targets, while risks include healthcare cost pressures and potential legal challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hewlett Packard Enterprise Co
Hewlett Packard Enterprise is an information technology vendor that provides hardware and software to enterprises. Its primary product lines are compute servers, storage arrays, and networking equipment.
Read more on HPE →About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →
